tanshinone has been researched along with Airflow Obstruction, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, Q; Hao, W; Miao, Y; Tian, D; Wang, P; Yang, N; Zhang, C | 1 |
1 other study(ies) available for tanshinone and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Tanshinone IIA protects against chronic obstructive pulmonary disease via exosome‑shuttled miR‑486‑5p.
Topics: Abietanes; Animals; Exosomes; Lipopolysaccharides; Mice; MicroRNAs; Pulmonary Disease, Chronic Obstructive; Salvia miltiorrhiza | 2022 |